Doping Case Study

1024 Words 5 Pages
The utilisation of denied medication or techniques to enhance preparation and game by competitors is called Doping ("What is doping? | United Nations Educational, Scientific and Cultural Organization", 2016). According to National Drug Strategy - Performance and Image Enhancing Drugs - Erythropoietin (2016), EPO manages the creation of red platelets in bone marrow and is a normally happening hormone delivered by cells in the kidneys; EPO is discharged from the kidney cells when the oxygen content in blood is low as theses kidney cells are delicate to low blood oxygen content; Moreover, to expand the oxygen conveying limit of the blood, EPO invigorates the bone marrow to deliver more red platelets. Dr Caillaud asserts that the blood itself is …show more content…
According to Marieb and Hoehn (2013) renal anemia is caused due to the deficiency of EPO, in which damaged kidneys cannot produce enough EPO. Therefore, the treatment instantly pulled in the consideration of competitors. Given that rHuEPO builds red platelet mass and practice limit in iron deficient patients, it may have the same impact in the competitor 's body, along these lines improving execution (Heuberger et al., 2013). With this method of reasoning, competitors began utilising rHuEPO, and the utilisation of rHuEPO was put on the International Olympic Committee 's rundown of disallowed substances in 1990 (Heuberger et al., 2013). The rundown has now been extended to all erythropoiesis-fortifying specialists (Heuberger et al., …show more content…
Erythropoietin use among aggressive cyclists was normal in the 1990s and supposedly added to no less than 18 passings ("Performance-enhancing drugs: Know the risks - Mayo Clinic", 2016). While appropriate utilization of EPO has a colossal remedial advantage in the treatment of frailty identified with kidney infection, its abuse can prompt genuine wellbeing dangers for competitors who utilize this substance just to pick up a focused edge ("EPO Detection", 2014). It is notable that EPO, by thickening the blood, prompts an expanded danger of a few destructive sicknesses, for example, coronary illness, and cerebral or pneumonic embolism ("EPO Detection", 2014). The abuse of recombinant human EPO may likewise prompt immune system illnesses with genuine wellbeing outcomes ("EPO Detection", 2014). Similarly, the wrong utilization of erythropoietin may build the danger of thrombotic occasions, for example, stroke, heart assault and aspiratory embolism ("Performance-enhancing drugs: Know the risks - Mayo Clinic", 2016). As a consequence, all medicines have reactions. However, taking them when your body does not need them can bring about genuine harm to your body and wreck the athletic vocation ("Dangers of Doping | World Dance Sport Federation at

Related Documents